Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-18

FDA Approved: CLINDAMYCIN IN 5 PERCENT DEXTROSE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for CLINDAMYCIN IN 5 PERCENT DEXTROSE from Sandoz Inc, establishing this generic formulation of clindamycin in 5% de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN IN 5 PERCENT DEXTROSE (clindamycin in 5% dextrose)

Snippet

SUPPL AP for CLINDAMYCIN IN 5 PERCENT DEXTROSE (CLINDAMYCIN IN 5 PERCENT DEXTROSE)